Trian, Solventum

Nelson Peltz’s Trian to Push Solventum to Further Simplify Business
Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in Apri
Trian to push Solventum to shed more businesses, WSJ reports
Nelson Peltz’s Trian Fund Management plans to push Solventum (SOLV) to separate more of its businesses after the company sold its filtration
Trian Fund Management pushes Solventum for further business separations - WSJ
Investing.com -- Activist investor Trian Fund Management is reportedly planning to urge Solventum to separate additional businesses following the company's $4.1 billion deal to sell its filtration unit, according to the Wall Street Journal, citing individuals who have knowledge of the situation.
Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business
Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in April 2024.
Trian Comments on Solventum’s Sale of its Purification & Filtration Business
Thermo Fisher’s release goes on to suggest that it believes it can more than double the profitability of Purification & Filtration under its corporate umbrella, relative to the business’ current profit as part of Solventum, with much of that improvement driven by lower allocated costs.
Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports
Feb 26 (Reuters) - Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum (SOLV.N), opens new tab for further business separations following the company's $4.1 billion ...
Thermo Fisher Buys Solventum's Purification and Filtration Business for $4.1 Billion
(Reuters) -Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and ...
Nelson Peltz's Strategic Moves: A Closer Look at Solventum Corp's Impact
The most notable increase was Solventum Corp (NYSE:SOLV), with an additional 1,336,564 shares, bringing the total to 8,462,819 shares. This adjustment represents a significant 18.76% increase in share ...
Solventum Corporation (SOLV): Among the Health Information Services Stocks Outpacing the Market in 2025
We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this article, we are going to take a look at where Solventum Corporation (NYSE:SOLV) ...
Solventum forecasts annual profit above estimates on strong surgical product sales
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.